As the immunology innovation company, argenx develops first-in-class medicines that change the course of disease and set a new direction for patients waiting for a breakthrough. Entrepreneurial Science shapes how we work: challenging conventions, pursuing bold pathways over conventional ones through the power of co-creation, and working alongside scientists, physicians and academic researchers with shared ambition — changing outcomes. Our purpose is to move immunology science faster than thought possible for patients who need progress now.
| Website | http://www.argenx.com |
| Ticker | NASDAQ:ARGX |
| Revenue | $1.9 billion |
| Employees | 2,363 (1,821 on RocketReach) |
| Founded | 2008 |
| Address | 33 Arch Street Suite 3201, Boston, Massachusetts 02110, US |
| Phone | +32 477 77 29 44 |
| Technologies |
JavaScript
,
HTML
,
Twitter
+33 more
(view full list)
|
| Industry | Biotechnology Research, Biotechnology, Differentiated antibodies, Science and Engineering, Niche indications, Clinical Trials, Oncology, Health Care, Autoimmune diseases, Therapeutics, Antibody-based drugs |
| Web Rank | 2 Million |
| Keywords | Immunology, Autoimmune Diseases, Biotechnology, Therapeutics, Pharmaceutical, Drug Development, Immunotherapy, Biopharma, Clinical Trials, Antibodies, Research, Biologics, Global Health, Precision Medicine, Patient Care, Healthcare, Rare Diseases, Innovation, Science, Medicine |
| Competitors | Roche, Genmab, Bristol Myers Squibb, Novartis, Amgen, Sanofi, AstraZeneca, Pfizer, Lilly India, Merck Group +43 more (view full list) |
Looking for a particular argenx employee's phone or email?
The argenx annual revenue was $1.9 billion in 2026.
Karl G is the CFO of argenx.
1,821 people are employed at argenx.
argenx is based in Boston, Massachusetts.